YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS

Sell AI employees under your own brand.

Agentic AI Comparison:
Healthcare CoPilot vs Laya

Healthcare CoPilot - AI toolvsLaya logo

Introduction

Healthcare Copilot and Laya serve different needs: the former’s official site now leads to Mizaic LEO for hospital referral workflows, while Laya is a developer component for structured decisions.

Overview

Healthcare CoPilot

Healthcare Copilot’s official destination now presents Mizaic LEO for referral workflows. LEO prepares referral information, supports clinical triage decisions and progresses approved outcomes through hospital systems. Clinicians retain decision authority.

Laya

Laya is an Apache-2.0 typed decision model. Developers supply text or JSON and typed questions, receive structured answers and probabilities, and connect those outputs to their own application. The project documents Python, HTTP serving, MCP and LangChain options.

Editorial ratings · 1–10, higher is better

These scores express our judgement of the cited product facts. They are not measured performance benchmarks. Each product is assessed for its stated purpose; a higher score does not make different workflows interchangeable.

Evidence gaps lower confidence and affect the relevant judgement. Unknown pricing does not mean free access. Research prototypes and retired products retain their historical scope, with adoption ratings reflecting current access.

Ratings assessed: 2026-11-09. Source verification dates may differ.

Documented capability: How useful and complete is the documented workflow for the product's stated purpose?

  • 1–2: No usable current workflow established, or only an unsupported promise.
  • 3–4: Historical, experimental or very limited workflow; substantial delivery gaps.
  • 5–6: Concrete but narrow workflow, or promising research requiring specialist review.
  • 7–8: Substantial documented end-to-end workflow with useful controls or customization.
  • 9–10: Exceptionally complete documented scope and controls; reserve 10 for unusually strong evidence.

Ease of adoption: Can the intended user obtain and set up a usable product today?

  • 1–2: Discontinued, unavailable, waitlisted, or no usable deployment path verified.
  • 3–4: Archived software, restricted research/preorder access or uncertain current service access.
  • 5–6: Developer-managed setup, significant configuration or sales-led implementation.
  • 7–8: Active accessible product with manageable setup for its intended user.
  • 9–10: Straightforward self-service access and setup, with unusually few adoption obstacles.

Value and cost clarity: How attractive and understandable is the cost model for the documented use?

  • 1–2: No current purchasable or usable offer; historical prices cannot support a purchase.
  • 3–4: Material price, entitlement, license or availability uncertainty limits budgeting.
  • 5–6: Plausible value with custom pricing, significant setup costs or incomplete selected-plan terms.
  • 7–8: Useful scope with clear entry pricing/allowances or accessible source, while accounting for running costs.
  • 9–10: Exceptionally accessible and clear cost model for substantial useful scope; never assume free compute.

Integration options: How useful and extensible are the verified user-facing connections for the intended workflow?

  • 1–2: No current user-facing connection verified, or former connections are unavailable.
  • 3–4: Inputs/exports or one focused connection; internal dependencies are not native connectors.
  • 5–6: Useful API, configurable tools or several relevant connections, with limited verified breadth.
  • 7–8: Broad relevant connections or an extensible documented API/MCP/tool ecosystem.
  • 9–10: Extensive documented ecosystem with multiple connection mechanisms and strong task relevance.

Metrics Comparison

Documented capability

Healthcare CoPilot: 8/10

Evidence confidence: medium

LEO covers referral preparation, triage support and progression of approved outcomes. This is a substantial focused workflow, with clinicians retaining decisions; the score does not imply proven clinical accuracy.

Laya: 7/10

Evidence confidence: medium

Typed questions, structured answers and probabilities form a useful configurable decision workflow. Its narrow component role requires application-level evaluation and action handling.

Subjective editorial ratings for each product’s stated purpose, based on the cited facts; these are not measured performance scores.

Ease of adoption

Healthcare CoPilot: 5/10

Evidence confidence: medium

Demo-led hospital implementation and connections to existing systems require organizational setup. This is a specialist deployment rather than immediate self-service access.

Laya: 6/10

Evidence confidence: high

The model and Python package offer a usable developer setup path, but deployment and task-specific testing remain the implementer’s responsibility.

Subjective editorial ratings for each product’s stated purpose, based on the cited facts; these are not measured performance scores.

Value and cost clarity

Healthcare CoPilot: 5/10

Evidence confidence: medium

The described workflow could reduce administrative effort, but buyers need a quote and implementation scope to judge total cost. Custom procurement limits upfront cost clarity.

Laya: 7/10

Evidence confidence: high

Apache-2.0 licensing makes source and model access clear. Hosting, compute and integration still contribute to total cost.

Subjective editorial ratings for each product’s stated purpose, based on the cited facts; these are not measured performance scores.

Integration options

Healthcare CoPilot: 6/10

Evidence confidence: medium

LEO describes e-RS and other referral channels plus PAS, EPR and EDMS connections. These are relevant hospital integrations, subject to deployment-specific confirmation.

Laya: 7/10

Evidence confidence: high

Documented HTTP, MCP and LangChain options make the typed decision component extensible within developer-built workflows.

Subjective editorial ratings for each product’s stated purpose, based on the cited facts; these are not measured performance scores.

Conclusions

Evaluate LEO for an implemented referral workflow with clinical oversight and hospital-system integration. Evaluate Laya when your developers need a configurable decision component and can own its evaluation, hosting and downstream actions. Laya does not provide LEO’s clinical workflow out of the box.

YOUR BRAND · YOUR CUSTOMERS · YOUR AI BUSINESS

Sell AI employees under your own brand.

Give businesses AI teams that own ongoing roles. Set your pricing, delegate routine coordination and build a recurring service.